Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,034 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients.
Palmerini T, Della Riva D, Benedetto U, Bacchi Reggiani L, Feres F, Abizaid A, Gilard M, Morice MC, Valgimigli M, Hong MK, Kim BK, Jang Y, Kim HS, Park KW, Colombo A, Chieffo A, Sangiorgi D, Biondi-Zoccai G, Généreux P, Angelini GD, Pufulete M, White J, Bhatt DL, Stone GW. Palmerini T, et al. Eur Heart J. 2017 Apr 7;38(14):1034-1043. doi: 10.1093/eurheartj/ehw627. Eur Heart J. 2017. PMID: 28110296 Free PMC article. Review.
How to fill the GAPS-I in secondary prevention: application of a strategy based on GLP1 analogues, antithrombotic agents, PCSK9 inhibitors, SGLT2 inhibitors and immunomodulators.
Sabouret P, Angoulvant D, Pathak A, Fysekidis M, Laterra G, Costa F, Angelini F, Bocchino PP, Montalescot G, Biondi-Zoccai G. Sabouret P, et al. Panminerva Med. 2022 Jun;64(2):265-273. doi: 10.23736/S0031-0808.21.04284-1. Epub 2021 Jun 1. Panminerva Med. 2022. PMID: 34060278 Review.
Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials.
Galli M, Benenati S, Franchi F, Rollini F, Capodanno D, Biondi-Zoccai G, Vescovo GM, Cavallari LH, Bikdeli B, Ten Berg J, Mehran R, Gibson CM, Crea F, Pereira NL, Sibbing D, Angiolillo DJ. Galli M, et al. Eur Heart J. 2022 Mar 7;43(10):959-967. doi: 10.1093/eurheartj/ehab836. Eur Heart J. 2022. PMID: 34918066 Free PMC article.
Comparing benefits from sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in randomized clinical trials: a network meta-analysis.
Sabouret P, Bocchino PP, Angelini F, D'Ascenzo F, Galati G, Fysekidis M, DE Ferrari GM, Fischman DL, Bhatt DL, Biondi-Zoccai G. Sabouret P, et al. Minerva Cardiol Angiol. 2023 Apr;71(2):199-207. doi: 10.23736/S2724-5683.22.05900-2. Epub 2022 Feb 23. Minerva Cardiol Angiol. 2023. PMID: 35195376 Free article.
Cardiovascular scholarly challenges following the Russian invasion of Ukraine.
Biondi-Zoccai G, Pirlamarla P, Sabouret P, Kozhukhov S, Marchenko O, Hill JA, Mamas MA. Biondi-Zoccai G, et al. Minerva Cardiol Angiol. 2022 Oct;70(5):525-528. doi: 10.23736/S2724-5683.22.06102-6. Epub 2022 Mar 28. Minerva Cardiol Angiol. 2022. PMID: 35343175 Free article. No abstract available.
1,034 results